PurposeTo develop a deep learning model - Cornea nnU-Net Extractor (CUNEX) - for full-thickness corneal segmentation of anterior segment optical coherence tomography (AS-OCT) images and evaluate its utility in artificial intelligence (AI) research. MethodsWe trained and evaluated CUNEX using nnU-Net on 600 AS-OCT images (CSO MS-39) from 300 patients: 100 normal, 100 keratoconus (KC), and 100 Fuchs endothelial corneal dystrophy (FECD) eyes. To assess generalizability, we externally validated CUNEX on 1,168 AS-OCT images from an infectious keratitis dataset acquired from a different device (Casia SS-1000). We benchmarked CUNEX against two recent models, CorneaNet and ScLNet. We then applied CUNEX to our dataset of 194,599 scans from 37,499 patients as preprocessing for a classification model evaluating whether segmentation improves AI prediction, including age, sex, and disease staging (KC and FECD). ResultsCUNEX achieved Dice similarity coefficient (DSC) and intersection over union (IoU) scores ranging from 94-95% and 90-99%, respectively, across healthy, KC, and FECD eyes. This was similar to ScLNet (within 3%) but better than CorneaNet (8-35% lower). On external validation, CUNEX maintained high performance (DSC 83%; IoU 71%) while ScLNet (DSC 14%; IoU 8%) and CorneaNet (DSC 16%; IoU 9%) failed to generalize. Unexpectedly, segmentation minimally impacted classification accuracy except for sex prediction, where accuracy dropped from 81 to 68%, suggesting sex-related features may lie outside the cornea. ConclusionCUNEX delivers the first open-source generalizable corneal segmentation model using the latest framework, supporting its use in clinical analysis and AI workflows across diseases and imaging platforms. It is available at https://github.com/lkandakji/CUNEX.

BackgroundIntracranial hemorrhage (ICH), whether spontaneous or traumatic, is a neurological emergency with high morbidity and mortality. Accurate assessment of severity is essential for neurosurgical decision-making. This study aimed to develop and evaluate a fully automated, deep learning-based tool for the standardized assessment of ICH severity, based on the segmentation of the hemorrhage and intracranial structures, and the computation of an objective severity index. MethodsNon-contrast cranial CT scans from patients with spontaneous or traumatic ICH were retrospectively collected from public datasets and a tertiary care center. Deep learning models were trained to segment hemorrhages and intracranial structures. These segmentations were used to compute a severity index reflecting bleeding burden and mass effect through volumetric relationships. Segmentation performance was evaluated on a hold-out test cohort. In a prospective cohort, the severity index was assessed in relation to expert-rated CT severity, clinical outcomes, and the need for urgent neurosurgical intervention. ResultsA total of 1,110 non-contrast cranial CT scans were analyzed, 900 from the retrospective cohort and 200 from the prospective evaluation cohort. The binary segmentation model achieved a median Dice score of 0.90 for total hemorrhage. The multilabel model yielded Dice scores ranging from 0.55 to 0.94 across hemorrhage subtypes. The severity index significantly correlated with expert-rated CT severity (p < 0.001), the modified Rankin Scale (p = 0.007), and the Glasgow Outcome Scale-Extended (p = 0.039), and independently predicted the need for urgent surgery (p < 0.001). A threshold [~]300 was identified as a decision point for surgical management (AUC = 0.83). ConclusionWe developed a fully automated and openly accessible pipeline for the analysis of non-contrast cranial CT in intracranial hemorrhage. It computes a novel index that objectively quantifies hemorrhage severity and is significantly associated with clinically relevant outcomes, including the need for urgent neurosurgical intervention.

IntroductionAccurately predicting Alzheimers Disease (AD) progression is useful for clinical care. The 2019 TADPOLE (The Alzheimers Disease Prediction Of Longitudinal Evolution) challenge evaluated 92 algorithms from 33 teams worldwide. Unlike typical clinical prediction studies, TADPOLE accommodates (1) variable number of observed timepoints across patients, (2) missing data across modalities and visits, and (3) prediction over an open-ended time horizon, which better reflects real-world data. However, TADPOLE only used the Alzheimers Disease Neuroimaging Initiative (ADNI) dataset, so how well top algorithms generalize to other cohorts remains unclear. MethodsWe tested five algorithms in three external datasets covering 2,312 participants and 13,200 timepoints. The algorithms included FROG, the overall TADPOLE winner, which utilized a unique Longitudinal-to-Cross-sectional (L2C) transformation to convert variable-length longitudinal histories into feature vectors of the same length across participants (i.e., same-length feature vectors). We also considered two FROG variants. One variant unified all XGBoost models from the original FROG with a single feedforward neural network (FNN), which we referred to as L2C-FNN. We also included minimal recurrent neural networks (MinimalRNN), which was ranked second at publication time, as well as AD Course Map (AD-Map), which outperformed MinimalRNN at publication time. All five models - three FROG variants, MinimalRNN and AD-Map - were trained on ADNI and tested on the external datasets. ResultsL2C-FNN performed the best overall. In the case of predicting cognition and ventricle volume, L2C-FNN and AD-Map were the best. For clinical diagnosis prediction, L2C-FNN was the best, while AD-Map was the worst. L2C-FNN also maintained its edge over other models, regardless of the number of observed timepoints, and regardless of the prediction horizon from 0 to 6 years into the future. ConclusionsL2C-FNN shows strong potential for both short-term and long-term dementia progression prediction. Pretrained ADNI models are available: https://github.com/ThomasYeoLab/CBIG/tree/master/stable_projects/predict_phenotypes/Zhang2025_L2CFNN.

A diagnostic medical foundation model (MedFM) is an artificial intelligence (AI) system engineered to accurately determine diagnoses across various medical imaging modalities and specialties. To train MedFM, we created the PubMed Central Medical Images Dataset (PMCMID), the largest annotated medical image dataset to date, comprising 16,126,659 images from 3,021,780 medical publications. Using AI- and ontology-based methods, we identified 4,482,237 medical images (e.g., clinical photos, X-rays, ultrasounds) and generated comprehensive annotations. To optimize MedFMs performance and assess biases, 13,266 images were manually annotated to establish a multimodal benchmark. MedFM achieved physician-level performance in diagnosis tasks spanning radiology, dermatology, and infectious diseases without requiring specific training. Additionally, we developed the Image2Paper app, allowing clinicians to upload medical images and retrieve relevant literature. The correct diagnoses appeared within the top ten results in 88.4% and at least one relevant differential diagnosis in 93.0%. MedFM and PMCMID were made publicly available. FundingResearch reported here was partially supported by the National Cancer Institute (NCI) (R01 CA260271), the Saudi Company for Artificial Intelligence (SCAI) Authority, and the German Federal Ministry for Economic Affairs and Climate Action (BMWK) under the project DAKI-FWS (01MK21009E). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

AO_SCPLOWBSTRACTC_SCPLOWThe quantification of the Ki-67 labeling index (LI) is critical for assessing tumor proliferation and prognosis in tumors, yet manual scoring remains a common practice. This study presents an automated workflow for Ki-67 scoring in whole slide images (WSIs) using an Apache Groovy code script for QuPath, complemented by a Python-based post-processing script, providing cell density maps and summary tables. The tissue and cell segmentation are performed using StarDist, a deep learning model, and adaptive thresholding to classify Ki-67 positive and negative nuclei. The pipeline was applied to a cohort of 632 pediatric brain tumor cases with 734 Ki-67-stained WSIs from the Childrens Brain Tumor Network. Medulloblastoma showed the highest Ki-67 LI (median: 19.84), followed by atypical teratoid rhabdoid tumor (median: 19.36). Moderate values were observed in brainstem glioma-diffuse intrinsic pontine glioma (median: 11.50), high-grade glioma (grades 3 & 4) (median: 9.50), and ependymoma (median: 5.88). Lower indices were found in meningioma (median: 1.84), while the lowest were seen in low-grade glioma (grades 1 & 2) (median: 0.85), dysembryoplastic neuroepithelial tumor (median: 0.63), and ganglioglioma (median: 0.50). The results aligned with the consensus of the oncology, demonstrating a significant correlation in Ki-67 LI across most of the tumor families/types, with high malignancy tumors showing the highest proliferation indices and lower malignancy tumors exhibiting lower Ki-67 LI. The automated approach facilitates the assessment of large amounts of Ki-67 WSIs in research settings.

We developed and tested a deep-learning-based algorithm for the approximation of contrast agent dosage based on computed tomography (CT) scout images. We prospectively enrolled 817 patients undergoing clinically indicated CT imaging, predominantly of the thorax and/or abdomen. Patient weight was collected by study staff prior to the examination 1) with a weight scale and 2) as self-reported. Based on the scout images, we developed an EfficientNet convolutional neural network pipeline to estimate the optimal contrast agent dose based on patient weight and provide a browser-based user interface as a versatile open-source tool to account for different contrast agent compounds. We additionally analyzed the body-weight-informative CT features by synthesizing representative examples for different weights using in-context learning and dataset distillation. The cohort consisted of 533 thoracic, 70 abdominal and 229 thoracic-abdominal CT scout scans. Self-reported patient weight was statistically significantly lower than manual measurements (75.13 kg vs. 77.06 kg; p < 10-5, Wilcoxon signed-rank test). Our pipeline predicted patient weight with a mean absolute error of 3.90 {+/-} 0.20 kg (corresponding to a roughly 4.48 - 11.70 ml difference in contrast agent depending on the agent) in 5-fold cross-validation and is publicly available at https://tinyurl.com/ct-scout-weight. Interpretability analysis revealed that both larger anatomical shape and higher overall attenuation were predictive of body weight. Our open-source deep learning pipeline allows for the automatic estimation of accurate contrast agent dosing based on scout images in routine CT imaging studies. This approach has the potential to streamline contrast agent dosing workflows, improve efficiency, and enhance patient safety by providing quick and accurate weight estimates without additional measurements or reliance on potentially outdated records. The models performance may vary depending on patient positioning and scout image quality and the approach requires validation on larger patient cohorts and other clinical centers. Author SummaryAutomation of medical workflows using AI has the potential to increase reproducibility while saving costs and time. Here, we investigated automating the estimation of the required contrast agent dosage for CT examinations. We trained a deep neural network to predict the body weight from the initial 2D CT Scout images that are required prior to the actual CT examination. The predicted weight is then converted to a contrast agent dosage based on contrast-agent-specific conversion factors. To facilitate application in clinical routine, we developed a user-friendly browser-based user interface that allows clinicians to select a contrast agent or input a custom conversion factor to receive dosage suggestions, with local data processing in the browser. We also investigate what image characteristics predict body weight and find plausible relationships such as higher attenuation and larger anatomical shapes correlating with higher body weights. Our work goes beyond prior work by implementing a single model for a variety of anatomical regions, providing an accessible user interface and investigating the predictive characteristics of the images.

Timely intervention for Alzheimers disease (AD) requires early detection. The development of immunotherapies targeting amyloid-beta and tau underscores the need for accessible, time-efficient biomarkers for early diagnosis. Here, we directly applied our previously developed MRI-based deep learning model for AD to the large Chinese SILCODE cohort (722 participants, 1,105 brain MRI scans). The model -- initially trained on North American data -- demonstrated robust cross-ethnic generalization, without any retraining or fine-tuning, achieving an AUC of 91.3% in AD classification with a sensitivity of 95.2%. It successfully identified 86.7% of individuals at risk of AD progression more than 5 years in advance. Individuals identified as high-risk exhibited significantly shorter median progression times. By integrating an interpretable deep learning brain risk map approach, we identified AD brain subtypes, including an MCI subtype associated with rapid cognitive decline. The models risk scores showed significant correlations with cognitive measures and plasma biomarkers, such as tau proteins and neurofilament light chain (NfL). These findings underscore the exceptional generalizability and clinical utility of MRI-based deep learning models, especially in large and diverse populations, offering valuable tools for early therapeutic intervention. The model has been made open-source and deployed to a free online website for AD risk prediction, to assist in early screening and intervention.